Because symptoms are usually nonspecific, in the absence of panhypopituitarism and low serum IGF-I levels, the diagnosis of AGHD requires biochemical confirmation with at least 1 GH stimulation test (1). This evidence concerns the gene IGF1 and panhypopituitarism.